TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · major macro event coming up
PRLD

Prelude Therapeutics Inc

Healthcare · Biotechnology

4.00$ +1.3% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Prelude Therapeutics Inc (PRLD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 189 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PRLD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
259 278 247 224 197 176 141 115 95 141 120 189
235 236 205 183 156 136 102 77 58 106 85 155
16 25 25 28 11 12 40 26 48 35 22 26
231 233 202 180 154 134 99 73 55 103 82 152
20 41 36 42 41 44 38 39 36 73 59 56
17 22 18 23 22 26 20 21 18 53 42 38
0.5 1.5 2.2 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.8 2.8
5.2 4.6 5.3 6.2 5.9 7.7 5.8 5.0 2.5 4.0 2.1 2.0
238 237 211 182 156 131 103 76 59 69 60 134
-423 -456 -488 -523 -555 -584 -616 -647 -667 -683 -693 -707
68 70 76 76 76 76 76 76 76 63 83 98

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?